Monoclonal Antibody Therapeutics Market to Surpass US$ 174.2 Billion Threshold by 2026

Monoclonal Antibody Therapeutics Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market – Overview
Monoclonal antibodies are a type of immunotherapy, which are made in a laboratory and are several copies
of a single antibody. Several monoclonal antibodies to treat inflammatory, cancer, and other diseases have
been approved by the U.S. Food & Drug Administration (FDA). Depending on the source, there are four
types of monoclonal antibodies: Murine, Chimeric, Humanized, and Human. Murine antibodies are
entirely derived from a murine source, chimeric antibodies contain variable regions from murine origin and
constant regions from human origin. Humanized antibodies are derived from a human source with a small
part of a mouse or rat monoclonal antibody and human antibodies are entirely derived from a human
source.
Monoclonal antibodies are majorly used in cancer treatment along with certain inflammatory, infectious,
and other diseases. Depending upon the functions of monoclonal antibodies (for cancer) they are further
classified into subtypes such as radiolabeled antibodies, chemo labeled antibodies, and bispecific
monoclonal antibodies. Commercially available monoclonal antibodies include, Iplimumab, Nivolumab,
Rituximab, Blinatumomab, Proleukin, Gardasil, and Kymriah.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market Taxonomy:
Global Monoclonal Antibody Therapeutics Market, By Source:
Human
Humanized
Chimeric
Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application:
Oncology
Autoimmune Diseases
Infectious Diseases
Hematological Disorders
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2403
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market: Key Players
●
Pfizer, Inc.
●
Novartis International AG
●
Amgen, Inc.
●
Sanofi S.A.
●
Merck & Co., Inc.
●
GlaxoSmithKline Plc
●
F. Hoffmann-La Roche Ltd
●
AbbVie, Inc
●
Eily, Lilly
View this report @
https://www.coherentmarketinsights.com/market-insight/monoclonal-antibody-therapeutics-market-2403
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To know more about us, visit our website:
www.coherentmarketinsights.com
THANK YOU
© Coherent market Insights. All Rights Reserved
For sales queries or new topics emailus on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Several monoclonal antibodies to treat inflammatory, cancer, and other diseases have been approved by the U.S. Food & Drug Administration (FDA).